Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143812 |
| CAS No | NA |
| Mol.F. | C14H13D3N4O2 |
| Mol.Wt. | 275.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143813 |
| CAS No | NA |
| Mol.F. | C14H13D3N4O2 |
| Mol.Wt. | 275.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143814 |
| CAS No | NA |
| Mol.F. | C11H18N2O3 |
| Mol.Wt. | 226.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143815 |
| CAS No | NA |
| Mol.F. | C18H21F6N3O4 |
| Mol.Wt. | 457.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143816 |
| CAS No | NA |
| Mol.F. | C19H21FN4O5 |
| Mol.Wt. | 404.4 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143817 |
| CAS No | NA |
| Mol.F. | C11H6F2N2O5 |
| Mol.Wt. | 284.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143817 |
| CAS No | NA |
| Mol.F. | C11H6F2N2O5 |
| Mol.Wt. | 284.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143818 |
| CAS No | NA |
| Mol.F. | C10H4F2N2O5 |
| Mol.Wt. | 270.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143819 |
| CAS No | NA |
| Mol.F. | C13H10F2N2O5 |
| Mol.Wt. | 312.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143820 |
| CAS No | NA |
| Mol.F. | C19H38N6O8 |
| Mol.Wt. | 478.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143821 |
| CAS No | NA |
| Mol.F. | C20H40N6O8 |
| Mol.Wt. | 492.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143822 |
| CAS No | NA |
| Mol.F. | C20H40N6O8 |
| Mol.Wt. | 492.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143823 |
| CAS No | NA |
| Mol.F. | C20H40N6O8 |
| Mol.Wt. | 492.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143824 |
| CAS No | NA |
| Mol.F. | C20H40N6O8 |
| Mol.Wt. | 492.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143825 |
| CAS No | NA |
| Mol.F. | C20H40N6O10 |
| Mol.Wt. | 524.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143826 |
| CAS No | NA |
| Mol.F. | C20H40N6O10 |
| Mol.Wt. | 524.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |